Delphinus Medical Technologies Inc.
This article was originally published in Start Up
Delphinus Medical Technologies Inc. is applying underwater sound wave technology to more accurately and safely detect breast cancer. The Michigan-based company, a spin-out of the Barbara Ann Karmanos Cancer Institute in Detroit, has developed a full-breast ultrasound tomography system that quickly and effectively differentiates benign from malignant breast masses without compression or radiation exposure.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.